肾皮质体积:与活体肾捐献者术前及术后肾功能高度相关
本研究回顾性评估三种CT体积测量技术在105例法国活体肾捐献者中估测术前肾功能及预测术后1年慢性肾病风险的价值,以51Cr-EDTA闪烁显像测定的肾小球滤过率为参考。肾皮质体积法保留肾体积与术后mGFR相关性最强(R=0.60),预测术后1年CKD的AUC最高(0.80)。作者认为肾皮质体积法似乎是替代闪烁显像估测术前分肾功能和预测术后肾脏结局的最佳体积测量技术。
要点
- 肾皮质体积(RCoV)与术后mGFR相关性最强(R=0.60),优于3DRV(R=0.39)和RVCt(R=0.51)。
- RCoV预测术后1年CKD的AUC为0.80,高于RVCt(0.76)和3DRV(0.70)。
- 三种CT体积测量技术之间高度相关(R>0.84),保留肾术前中位体积RCoV为99 cm³。
核心结论
- 在健康活体肾捐献者队列中,肾皮质体积法(RCoV)似乎是替代闪烁显像估测术前分肾功能和预测术后肾脏结局的最佳体积测量技术。
研究设计与样本
- 回顾性研究,纳入105例活体肾捐献者,术前采用三种CT体积测量方法(3DRV、RVCt、RCoV)量化肾脏体积,并以51Cr-EDTA闪烁显像测定的mGFR为参考,术前及术后1年各测量一次。
关键影像表现/征象
- 保留肾术前中位体积:3DRV法156 cm³、RVCt法163 cm³、RCoV法99 cm³,各技术间高度相关(R>0.84)。
- 所有方法测得的全肾体积均与术前mGFR显著相关(P<0.001)。
诊断标准与关键数值
- 保留肾体积与术后mGFR显著相关(P<0.0001),RCoV相关性最强(R=0.60),3DRV为R=0.39、RVCt为R=0.51。
- 预测术后1年CKD的AUC:RCoV为0.80,RVCt为0.76,3DRV为0.70。
临床应用与阅片要点
- 作者认为肾皮质体积法(RCoV)似乎是替代闪烁显像估测术前分肾功能和预测术后肾脏结局的最佳体积测量技术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: CT volumetry has previously been proposed as an alternative to scintigraphy for the evaluation of pre-donation split renal function and the prediction of post-donation renal function in living kidney donors. The aim of our study was to retrospectively assess the relevance of three CT volumetry techniques for estimating pre-donation kidney function and predicting the risk for chronic kidney disease (CKD) at 1-year post-nephrectomy in a French cohort of living donors using isotopic measures of kidney function.
METHODS: Kidney volume was quantified pre-donation for 105 donors using three methods total parenchymal three-dimensional renal volume (3DRV), total parenchymal renal volume contouring (RVCt), and renal cortical volume (RCoV). Subjects also had a 51Cr-EDTA scintigraphy to measure glomerular filtration rate (mGFR) pre-donation and 1-year after donation. For each volume, we tested for association with mGFR using univariate regression models, and computed receiver operating characteristics analyses to assess their predictive potential of post-donation CKD.
RESULTS: Our population was composed of healthy subjects, who were predominantly female (69%) with a median age at donation of 51yo. Median mGFR was 102 mL/min/1.73 m2 at pre-donation and 66 mL/min/1.73 m2 1-year after nephrectomy. The pre-donation median volume of the preserved kidney was 156 cm3, 163 cm3 and 99 cm3 for the 3DRV, RVCt and RCoV methods respectively, with a high correlation observed between each technique (R > 0.84). For all methods, total kidney volume was significantly associated with pre-donation mGFR (P < 0.001). Preserved kidney volume was also strongly correlated with post-donation mGFR (P < 0.0001), with the strongest correlation observed for RCoV (R = 0.60 vs. R = 0.39 and R = 0.51 for 3DRV and RVCt, respectively). Finally, the RCoV method yielded the best predictive value of 1-year post-donation CKD (AUC = 0.80 vs. AUC = 0.76 and 0.70 for RVCt and 3DRV, respectively).
CONCLUSIONS: In our cohort of healthy donors with measured kidney function, cortical volumetry (RCoV) appears as the best volumetric technique to use as a surrogate to scintigraphy for estimating pre-donation split renal function and predicting post-donation renal outcomes.
引用
- Gardan E, Jacquemont L, Perret C, et al. Renal cortical volume: High correlation with pre- and post-operative renal function in living kidney donors. Eur J Radiol. 2017. PMID: 29362141. doi:10.1016/j.ejrad.2017.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。